Risk of Subclinical Atherosclerosis in Patients with Antiphospholipid Syndrome and Subjects With Antiphospholipid Antibody Positivity: A Systematic Review and Meta-analysis.
Curr Probl Cardiol
; 48(6): 101672, 2023 Jun.
Article
en En
| MEDLINE
| ID: mdl-36841314
ABSTRACT
Currently, the guidelines for the prevention of atherosclerosis in patients with antiphospholipid syndrome (APS) do not differ substantially from those in the general population. We aimed to assess the risk of subclinical atherosclerosis in patients with APS and subjects with antiphospholipid antibody (aPL) positivity. Systematic literature search was conducted through Medline and Scopus until January 2023. Random effects meta-analyses were performed to examine the differences in markers of subclinical atherosclerosis between APS patients, subjects positive for aPLs and healthy controls. Patients with APS had significantly higher values of common carotid artery (CCA) intima-media thickness (IMT) (MDâ¯=â¯0.07 mm; P < 0.0001), internal carotid artery IMT (MDâ¯=â¯0.06 mm; P < 0.01), carotid bifurcation IMT (MDâ¯=â¯0.14 mm; P < 0.01) and were more frequently diagnosed with atherosclerotic plaques compared to controls (ORâ¯=â¯3.73; P < 0.01). Similarly, APS patients showed a decreased flow and nitrate-mediated dilation (MDâ¯=â¯-4.52 %; <0.01, MDâ¯=â¯-1.25 %; P < 0.05, respectively). Interestingly, comparable were the results for subjects with aPL positivity, who had higher CCA-IMT (MDâ¯=â¯0.06 mm; P < 0.01) and higher prevalence of atherosclerotic plaques (ORâ¯=â¯2.59; Pâ¯=â¯0.08) compared to controls. Sensitivity analysis conducted on primary APS patients revealed that the risk of atherosclerosis is associated with APS per se and is not exclusively driven by other underlying conditions. Patients with APS and subjects with aPLs have an increased risk of subclinical atherosclerosis and require early and disease-specific prevention of atherosclerosis.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Síndrome Antifosfolípido
/
Aterosclerosis
/
Placa Aterosclerótica
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Guideline
/
Risk_factors_studies
/
Systematic_reviews
Límite:
Humans
Idioma:
En
Revista:
Curr Probl Cardiol
Año:
2023
Tipo del documento:
Article